Your browser doesn't support javascript.
Vaccines and Therapies in Development for SARS-CoV-2 Infections.
Wu, David; Koganti, Raghuram; Lambe, Upendra P; Yadavalli, Tejabhiram; Nandi, Shyam S; Shukla, Deepak.
  • Wu D; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA.
  • Koganti R; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA.
  • Lambe UP; National Institute of Virology, Indian Council of Medical Research, Mumbai 400012, India.
  • Yadavalli T; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA.
  • Nandi SS; National Institute of Virology, Indian Council of Medical Research, Mumbai 400012, India.
  • Shukla D; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA.
J Clin Med ; 9(6)2020 Jun 16.
Article in English | MEDLINE | ID: covidwho-599305
ABSTRACT
The current COVID-19 pandemic is caused by the novel coronavirus SARS-CoV-2. The virus causes severe respiratory symptoms which manifest disproportionately in the elderly. Currently, there are over 6.5 million cases and 380,000 deaths reported. Given the current severity of the outbreak, there is a great need for antiviral therapies and vaccines to treat and prevent COVID-19. In this review, we provide an overview of SARS-CoV-2 and discuss the emerging therapies and vaccines that show promise in combating COVID-19. We also highlight potential viral targets that could be exploited by researchers and drug manufacturers.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Vaccines Language: English Year: 2020 Document Type: Article Affiliation country: Jcm9061885

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Vaccines Language: English Year: 2020 Document Type: Article Affiliation country: Jcm9061885